Castleark Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-125,727
| Closed | -$3.18M | – | 322 |
|
|
2023
Q2 | $3.18M | Buy |
125,727
+23,140
| +23% | +$586K | 0.14% | 148 |
|
|
2023
Q1 | $3.3M | Buy |
102,587
+44,220
| +76% | +$1.42M | 0.16% | 135 |
|
|
2022
Q4 | $1.08M | Sell |
58,367
-79,980
| -58% | -$1.48M | 0.06% | 191 |
|
|
2022
Q3 | $3.74M | Buy |
138,347
+9,034
| +7% | +$244K | 0.21% | 122 |
|
|
2022
Q2 | $1.79M | Buy |
+129,313
| New | +$1.79M | 0.1% | 169 |
|